
Results
12
12 companies
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.5b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$9.00
7D
-0.4%
1Y
9.6%
Tong Ren Tang Technologies
Market Cap: HK$5.7b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.42
7D
-0.5%
1Y
-7.7%
Consun Pharmaceutical Group
Market Cap: HK$16.3b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$19.36
7D
5.9%
1Y
133.8%
Shandong Xinhua Pharmaceutical
Market Cap: HK$10.3b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$6.99
7D
-0.1%
1Y
22.6%
Essex Bio-Technology
Market Cap: HK$2.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.45
7D
4.0%
1Y
63.6%
CSPC Pharmaceutical Group
Market Cap: HK$117.2b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$10.25
7D
-0.7%
1Y
112.2%
Zhongzhi Pharmaceutical Holdings
Market Cap: HK$630.4m
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China.
3737
HK$0.73
7D
-2.7%
1Y
-24.0%
China Shineway Pharmaceutical Group
Market Cap: HK$7.4b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$9.79
7D
-1.2%
1Y
17.5%
Shanghai Haohai Biological Technology
Market Cap: HK$10.8b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$26.72
7D
-0.07%
1Y
2.8%
Pak Fah Yeow International
Market Cap: HK$741.7m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.38
7D
-0.8%
1Y
-2.9%
Jacobson Pharma
Market Cap: HK$2.5b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.27
7D
0.8%
1Y
2.4%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.8b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.21
7D
1.7%
1Y
1.7%